semaglutide fda drug shortage list Shortages Tirzepatide is NO longer in

,

After discussion with their provider, patients may be escalated to higher doses like 12.5mg or 15mg, depending upon their individual health and wellness goals

Molecules 25 , 5591 (2020)

The authors noted that the increase in prescriptions could be tied to the explosion in interest in GLP-1 medications for weight loss, as well as greater acceptance for using anti-obesity drugs

The lawsuits allege that Novo Nordisk failed to adequately warn users about the risks of developing serious side effects, particularly gastroparesis

Why Individuals Stop Taking GLP-1 People might stop taking GLP-1 medications for several reasons, from cost issues to trouble accessing medication